Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Summit Therapeutics plc (SMMT) Prices 1.46M ADS Offering at $12/Sh
-
Blue Apron (APRN) Headwinds Are Temporary - Canaccord
-
Summit Therapeutics Announces Pricing of Public Offering of 1,459,000 American Depositary Shares
-
Summit Therapeutics (SMMT) Announces Offering of $15M of ADSs
-
Summit Therapeutics Announces Proposed Public Offering of $15.0 Million of American Depositary Shares
-
Financial 15 Split Corp. Announces Overnight Offering
-
Iphone X shipping delay may dampen Apple's holiday quarter
-
Pre-Open Stock Movers 09/13: (SNAK) (ALDX) (JWN) Higher; (DCTH) (AMRK) (WDC) Lower (more...)
-
Tactile Systems Technology, Inc. (TCMD) Prices 3.3M Secondary at $33/Sh
-
Tactile Systems Technology (TCMD) Prices 3.3M Secondary Common Stock Offering at $33/Share
-
Tactile Medical Announces Pricing of Secondary Offering of Common Stock
-
Belden, Inc. (BDC) PT Raised to $88 at Canaccord Genuity
-
Aldeyra Therapeutics (ALDX) PT Raised to $27 at Canaccord Genuity
-
Perrigo Co. (PRGO) PT Raised to $100 at Canaccord Genuity Following Meeting With Management
-
Canaccord Says Apple (AAPL) Met Expectations With New iPhone, Introduces FY 2019 Estimates
-
Canaccord Genuity Assumes Aurinia Pharmaceuticals (AUPH) at Spec. Buy, Sees Co. As Attractive Partnering Candidate
-
AltaGas Ltd. Announces Revision to Ex-Dividend Date
-
Harvey, Irma to hit U.S. apparel retailers more than restaurants
-
Tactile Systems Technology, Inc. (TCMD) to Offer 2.75M Shares
-
Tactile Medical Announces Secondary Offering of Common Stock
-
UPDATE: Sage Therapeutics (SAGE) PT Lowered to $81 at Canaccord Genuity
-
UPDATE: Health Insurance Innovations (HIIQ) Should Win Back Confidence in Time - Canaccord Genuity
-
Fibrocell Science (FCSC): Raising PT to $7 Ahead of RDEB Ph1 Results - Canaccord
-
Vernalis plc: Results Announcement for the year ended 30 June 2017
-
PREIT Closes Preferred Share Offering
-
LOGiQ Asset Management and Purpose Investments Announce Retail Asset Management Transaction
-
AltaGas Ltd. Announces Monthly Dividend
-
ORBCOMM (ORBC) PT Raised to $16 at Canaccord Genuity After Meeting with Management
-
Laboratory Corporation of America (LH) PT Raised to $180 at Canaccord Genuity, Maintains Buy & Top Pick Choice
-
Initial revised mineral resource modeling approach for two veins at Curraghinalt show increase in ounces
-
Quidel to Participate in the CEO Series Conference Call Hosted by Canaccord Genuity
-
Generac Holdings (GNRC) PT Raised to $42 at Canaccord Genuity
-
Advanced Micro Devices (AMD): The Path Toward $1.00+ EPS - Canaccord
-
NVIDIA (NVDA): Raising Estimates After Attending Hot Chips - Canaccord
-
UPDATE: Canaccord Genuity Upgrades RLJ Lodging Trust (RLj) to Buy
-
Kratos Defense (KTOS) Announces 14M Share Common Offering at $12.25/Sh
-
Kratos Defense & Security Solutions, Inc. Prices Offering of Common Stock
-
PREIT Prices Series D Preferred Share Offering
-
Descartes (DSGX) PT Raised to $30 at Canaccord Genuity Following 2Q
-
Absolute Announces Approval of Normal Course Issuer Bid
-
Canaccord Genuity Resumes Endeavour Silver Corp (EXK) at Hold
-
Canaccord Genuity Resumes Hecla Mining (HL) at Hold
-
Canaccord Genuity Resumes Coeur d'Alene Mines (CDE) at Buy
-
Canaccord Genuity Resumes Pan Am Silver (PAAS) at Buy
-
Canaccord Genuity Resumes Fortuna Silver Mines (FSM) at Buy, Listed as Top Pick & Adds To Focus List
-
Dave & Buster's (PLAY) PT Lowered to $72 at Canaccord Genuity on 2Q Report; 'New Store Performance Exceeding Expectations... Comps Slow'
-
Critical Elements Announces Positive Feasibility Study with a Pre-Tax NPV 8% of $1.257 B and a Pre-Tax IRR of 48.2% for Its Rose Lithium Project
-
Canaccord Genuity Starts AAR Corporation (AIR) at Hold
-
Canaccord Genuity Downgrades Rockwell Collins (COL) to Hold Following Acquisition
-
Ambarella (AMBA) PT Lowered to $58 at Canaccord Genuity

